These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6396036)

  • 21. [Activity of the clearing factor in the pathogenesis of hyperlipidemia in experimental nephrotic syndrome].
    Nikiforova NV
    Biull Eksp Biol Med; 1966 Dec; 62(12):29-32. PubMed ID: 6005418
    [No Abstract]   [Full Text] [Related]  

  • 22. Ischaemic heart disease, lipids and the kidney.
    Brown JH; Short CD; Mallick NP
    Contrib Nephrol; 1993; 102():198-219. PubMed ID: 8416183
    [No Abstract]   [Full Text] [Related]  

  • 23. [Dyslipidemias in renal diseases: pathogenesis and treatment].
    Cuevas A; Maíz A; Arteaga A
    Rev Med Chil; 1998 Mar; 126(3):315-21. PubMed ID: 9674303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lipolytic enzyme activity in the plasma of patients with nephrotic syndrome].
    Nikiforova NV; Shallaeva VV; Malakhova EA; Zolotova TA; Miroshnichenko NG
    Vestn Akad Med Nauk SSSR; 1985; (11):45-51. PubMed ID: 4090653
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pathophysiology of lipoprotein metabolism].
    Windler E; Jäckle S; Rinninger F; Greten H
    Z Gastroenterol Verh; 1991 Mar; 26():98-9. PubMed ID: 1714219
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatic triglyceride and lipoprotein lipase activities of post-heparin plasma in normals and hypertriglyceridemics.
    Boberg J; Boberg M; Gross R; Turner JD; Augustin J; Brown WV
    Ups J Med Sci; 1979; 84(3):215-27. PubMed ID: 543050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
    Breier C
    Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Determination of total plasma lipoprotein lipase in patients with vascular diseases and hyperlipemia].
    Ferlito S; Puleo F; Carrá G; La Spina E; Del Campo F
    G Clin Med; 1980 Mar; 61(3):221-30. PubMed ID: 7390093
    [No Abstract]   [Full Text] [Related]  

  • 29. [Lipid metabolism disorders in chronic kidney failure].
    Lacour B; Roullet JB; Drueke T
    Nephrologie; 1983; 4(2):75-83. PubMed ID: 6348572
    [No Abstract]   [Full Text] [Related]  

  • 30. [Idiopathic nephrotic syndrome. II. Humoral disorders and complications].
    Klinger M; Szewczyk Z
    Przegl Lek; 1989; 46(8):659-63. PubMed ID: 2594999
    [No Abstract]   [Full Text] [Related]  

  • 31. Hyperlipoproteinaemia in renal failure: pathogenesis and perspectives for intervention.
    Attman PO
    Nephrol Dial Transplant; 1993; 8(4):294-5. PubMed ID: 8390000
    [No Abstract]   [Full Text] [Related]  

  • 32. [Relative concentration of VLDL C-apolipoproteins in the hyperlipoproteinaemia of haemodialysis-treated chronic renal failure (author's transl)].
    Dewailly P; Dedonder E; Fruchart JC; Sezille G; Jaillard J
    Diabete Metab; 1980 Mar; 6(1):13-6. PubMed ID: 7371894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-prandial lipoprotein metabolism in nephrotic syndrome.
    Warwick GL; Packard CJ; Stewart JP; Watson TD; Burns L; Boulton-Jones JM; Shepherd J
    Eur J Clin Invest; 1992 Dec; 22(12):813-20. PubMed ID: 1478253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperlipidemia in patients with chronic renal disease.
    Kasiske BL
    Am J Kidney Dis; 1998 Nov; 32(5 Suppl 3):S142-56. PubMed ID: 9820472
    [No Abstract]   [Full Text] [Related]  

  • 35. Postheparin plasma lipoprotein lipase activity in heterozygotes of familial lipoprotein lipase deficiency.
    Kondo Y; Kurobane I; Omura K; Sano R; Abe R; Chida N; Tada K
    Tohoku J Exp Med; 1985 Jan; 145(1):1-6. PubMed ID: 3983953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lipid metabolism disorders in kidney failure].
    Romics L; Makó J
    Orv Hetil; 1978 Dec; 119(50):3055-8. PubMed ID: 215956
    [No Abstract]   [Full Text] [Related]  

  • 37. Dyslipidemia in pediatric renal disease: epidemiology, pathophysiology, and management.
    Saland JM; Ginsberg H; Fisher EA
    Curr Opin Pediatr; 2002 Apr; 14(2):197-204. PubMed ID: 11981290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal failure in nephrotic syndrome.
    McCracken BH
    Lancet; 1968 Apr; 1(7547):870. PubMed ID: 4171372
    [No Abstract]   [Full Text] [Related]  

  • 39. [Changes in serum lipoproteins in kidney diseases. Clinical and pathogenetic aspects].
    Walther A; Mordasini R; Riesen W
    Dtsch Med Wochenschr; 1983 Mar; 108(10):385-7. PubMed ID: 6825580
    [No Abstract]   [Full Text] [Related]  

  • 40. Lipoprotein fractions, lipoprotein lipase and hepatic triglyceride lipase during short-term and long-term uptake of ethanol in healthy subjects.
    Schneider J; Liesenfeld A; Mordasini R; Schubotz R; Zöfel P; Kubel F; Vandré-Plozzitzka C; Kaffarnik H
    Atherosclerosis; 1985 Nov; 57(2-3):281-91. PubMed ID: 4084359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.